Form of Proxy

Approval of the 2025 Company financial statements

Approval of the 2025 consolidated financial statements

Appropriation of earnings and setting of the dividend

Regulated Agreements – Special Report of the Statutory auditors

Approval of the report on the compensation of corporate officers relating to the information detailed in Article L. 22-10-9 I of the French Commercial Code

Approval of fixed, variable and exceptional components of total compensation and all types of benefits paid during fiscal year 2025 or granted in respect of the same fiscal year to Mr. Paul Hermelin, Chairman of the Board of Directors

Approval of fixed, variable and exceptional components of total compensation and all types of benefits paid during fiscal year 2025 or granted in respect of the same fiscal year to Mr. Aiman Ezzat, Chief Executive Officer

Approval of the compensation policy applicable to the Chairman of the Board of Directors

Approval of the compensation policy applicable to the Chief Executive Officer

Increase in the total compensation amount for Directors and approval of the compensation policy applicable to Directors

Renewal of the term of office of Mr. Paul Hermelin as a director

Renewal of the term of office of Ms. Maria Ferraro as a director

Ratification of the co-optation of Ms. Lila Tretikov as a director

Appointment of Ms. Vronique Weill as a director

Appointment of Mr. Luc Rmont as a director

Renewal of the term of office of Forvis Mazars as Statutory auditor responsible for certifying the financial statements

Appointment of Grant Thornton as Statutory auditor responsible for certifying the financial statements

Renewal of the term of office of Forvis Mazars as Statutory auditor responsible for certifying sustainability information

Authorization of a share buyback program

Authorization to the Board of Directors, for a period of twenty-six months, to cancel shares bought back by the Company under the share buyback programs

Delegation of authority to the Board of Directors, for a period of twenty-six months, to increase the share capital by a maximum par value amount of €1.5 billion by capitalizing additional paid-in capital, reserves, profits or any other amounts

Delegation of authority to the Board of Directors, for a period of twenty-six months, to issue, with retention of pre-emptive subscription rights, ordinary shares and/or securities granting access to the Company’s share capital, immediately or in the future

Delegation of authority to the Board of Directors, for a period of twenty-six months, to issue, with cancellation of pre-emptive subscription rights, ordinary shares and/or securities granting access, immediately or in the future, to the Company’s share capital by way of public offers other than those referred to in Article L. 411-2 1o of the Frenc

Delegation of authority to the Board of Directors, for a period of twenty-six months, to issue, with cancellation of pre-emptive subscription rights, ordinary shares and/or securities granting access, immediately or in the future, to the Company’s share capital by way of public offers referred to in Article L. 411-2 1o of the French Monetary and Fi

Delegation of authority to the Board of Directors, for a period of twenty-six months, to increase the number of securities to be issued in the event of a share capital increase (through the issue of ordinary shares or securities granting access to the share capital, immediately or in the future) with retention or cancellation of pre-emptive subscri

Authorization to the Board of Directors, for a period of twenty-six months, to issue ordinary shares and/or securities granting access to the Company’s share capital, in consideration for contributions in kind to the Company of equity securities or securities granting access to share capital, immediately or in the future

Authorization to the Board of Directors, for a period of eighteen months, to grant performance shares, existing or to be issued, to employees and corporate officers of the Company and its French and non-French subsidiaries, up to a maximum of 1.2% of the Company’s share capital (with, in the case of shares to be issued, the waiver by shareholders o

Delegation of authority to the Board of Directors, for a period of eighteen months, to issue, with cancelation of pre-emptive subscription rights, ordinary shares and/or securities granting access to the Company’s share capital to members of Capgemini Group employee savings plans up to a maximum par value amount of €28 million and at a price set in

Delegation of authority to the Board of Directors, for a period of eighteen months, to issue with cancelation of pre-emptive subscription rights, ordinary shares and/or securities granting access to the share capital in favor of a specific category of beneficiaries for the set-up of structured offers for employees of certain non-French subsidiaries

Powers to carry out formalities